N. Satomi

发表

Traditional Chinese Medicines and Drugs in Relation to the Host-Defense Mechanism

A. Sakurai, N. Satomi, R. Haranaka, 1989 .

Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophages.

A. Sakurai, N. Satomi, K. Haranaka, 1985, Journal of the National Cancer Institute.

Inhibition of tumor-induced migration of bovine capillary endothelial cells by mouse and rabbit tumor necrosis factor.

N. Sato, H. Nariuchi, N. Satomi, 1987, Journal of the National Cancer Institute.

Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity.

N. Sato, H. Nariuchi, N. Satomi, 1986, Journal of the National Cancer Institute.

Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice

A. Sakurai, N. Satomi, K. Haranaka, 1984, International journal of cancer.

Antitumour effects of tumour necrosis factor: cytotoxic or necrotizing activity and its mechanism.

A. Sakurai, N. Satomi, R. Haranaka, 2007, Ciba Foundation symposium.

Antitumor Activity of Recombinant Human Tumor Necrosis Factor(rhTNF) in Combination with Hyperthermia Against Prostate Cancer in Nude Mice.

A. Sakurai, N. Satomi, K. Haranaka, 1991 .

PURIFICATION AND PARTIAL AMINO ACID SEQUENCE OF RABBIT TUMOR NECROSIS FACTOR

A. Sakurai, H. Nariuchi, N. Satomi, 1985, International journal of cancer.

Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro.

N. Satomi, K. Haranaka, 1981, The Japanese journal of experimental medicine.

Antitumor activity of combination therapy with traditional Chinese medicine and OK432 or MMC.

A. Sakurai, N. Satomi, R. Haranaka, 1988, Journal of biological response modifiers.

Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy.

A. Sakurai, N. Satomi, K. Haranaka, 1987, Journal of biological response modifiers.

Preventive effect of several drugs againstPseudomonas aeruginosa infection and the toxicity of combined tumor necrosis factor with lipopolysaccharide: Relationship between lethality and the arachidonic cascade

A. Sakurai, N. Satomi, R. Haranaka, 1990, Biotherapy.

ESTABLISHMENT AND CHARACTERIZATION OF HUMAN MYELOMONOCYTIC (TYS) AND HISTIOCYTIC (TYH) CELL LINES

A. Sakurai, N. Satomi, R. Haranaka, 1985, International journal of cancer.

Necrotizing activity of tumor necrosis factor: histopathological investigation using Meth A sarcoma and granulation tissue

A. Sakurai, T. Kawai, N. Satomi, 1987, Virchows Archiv. B, Cell pathology including molecular pathology.

Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs

A. Sakurai, N. Satomi, R. Haranaka, 1985, Cancer Immunology, Immunotherapy.

Role of first stimulating agents in the production of tumor necrosis factor

A. Sakurai, N. Satomi, R. Haranaka, 2004, Cancer Immunology, Immunotherapy.

Tumour necrosis factor and the lysosomal enzymes of macrophages or macrophage-like cell line

A. Sakurai, N. Satomi, K. Haranaka, 2004, Cancer Immunology, Immunotherapy.

Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs.

A. Sakurai, N. Satomi, R. Haranaka, 1985, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

Differences in tumour necrosis factor productive ability among rodents.

A. Sakurai, N. Satomi, K. Haranaka, 1984, British Journal of Cancer.

Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia against heterotransplanted human prostatic carcinoma and its lymph node metastasis in nude mice.

A. Sakurai, N. Satomi, K. Haranaka, 1992, Molecular biotherapy.

The Combined use of Antibiotics and Specific Antibodies against Mouse Pseudomonas aeruginosa Infection In Vivo and the Phagocytosis of Peritoneal Exudate Cells In Vitro

A. Sakurai, N. Satomi, K. Haranaka, 1982 .

Role of lipid A in the production of tumor necrosis factor and differences in antitumor activity between tumor necrosis factor and lipopolysaccharide.

A. Sakurai, N. Satomi, K. Haranaka, 1984, The Tohoku journal of experimental medicine.

Research on the production site of tumor necrosis factor (TNF).

N. Satomi, K. Haranaka, O. Kunii, 1981, The Japanese journal of experimental medicine.

Preventive effects of several chemicals against lethality of recombinant human tumor necrosis factor.

A. Sakurai, N. Satomi, R. Haranaka, 1988, Journal of biological response modifiers.

Combination therapy with traditional Chinese medicines and Streptococcus pyogenes products (OK 432) for endogenous tumor necrosis factor therapy. A preliminary report.

A. Sakurai, N. Satomi, R. Haranaka, 1995, Cancer biotherapy.

Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor.

L. Old, N. Satomi, K. Haranaka, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Effects of tumor necrosis factor (TNF) on transplanted tumors induced by methylcholanthrene in mice

N. Sato, A. Sakurai, T. Kawai, 1986, Virchows Archiv. B, Cell pathology including molecular pathology.

Growth inhibitory and cytotoxic action of rabbit tumor necrosis factor against bovine capillary endothelial cells in vitro.

N. Sato, H. Nariuchi, N. Satomi, 1985 .